Boehringer Ingelheim names Gagandeep Singh as MD & Head- Human Pharma for India

28 June 2023 | News

Fostering a customer-focused culture with experience across complex health ecosystems

Germany-headquartered pharmaceutical firm Boehringer Ingelheim has announced the appointment of Gagandeep Singh as Managing Director and Head of Human Pharma India, effective July 10, 2023. He will also join the Board of Boehringer Ingelheim India.                          

Singh succeeds Vani Manja, who moved to Boehringer Ingelheim UK in February 2023. During her transition, Sandip Agrawal, Director of Finance and Administration, took over the added responsibility of Interim Managing Director. 

Gagandeep Singh started his career in pharmaceutical sales and has an experience of 20 years in leading corporate strategy at multinational pharmaceutical companies in India and other emerging markets. He has a deep understanding of healthcare industry and is dedicated to driving patient benefit through innovative medicines and sustainable care.

He joins Boehringer Ingelheim from AstraZeneca, where he was the Managing Director for India and Africa Cluster Head.



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account